Roll-over Study to Allow Continued Access to Ribociclib

RibociclibOngoingActive not recruitingPhase 4Open NCT05161195 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…